Obicetrapib and obicetrapib–ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia [ID6519]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 14 October 2026
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]Status:In developmentProgramme:Highly specialised technologies guidanceExpected publication date: TBC